Currently Open Funding Opportunities

Deadline	Title	Amount	Sponsored By	Research Area	Content
04/10/2026	American Liver Foundation: Pilot Research Awards	$50,000	American Liver Foundation	Basic Science, Clinical Research, Early Career, Junior Faculty, Liver, Organ Transplantation, Regenerative Medicine, Stem Cells, Translational Research	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. LOI due: April 10, 2026 Full submission due: May 15, 2026 Amount: $50,000 (0% indirect costs) Project period: one year ALF will accept applications focused on research areas listed: Liver transplantation Stem cells and stem cell biology Liver regeneration Advanced in vitro human liver models Gene- and cell-based therapies for liver disease
04/17/2026	Google.org Impact Challenge: AI for Science	$3,000,000	Google	Artificial Intelligence (AI), Cellular and Tissue Biology, Disease Mechanisms, Drug Discovery, Genomics, Neuroscience	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due April 17, 2026 Amont: up to $3,000,000 Project period: Three years This is an extensive LOI – not a full application with a detailed budget. Selected finalists will ultimately undergo an iterative proposal development process with the Google.org team. A budget estimate from $500,000 to $3 million, and general breakdown of that budget (3 to 5 categories), is requested at this stage. The program supports AI-driven research across multiple areas of health and life sciences, including functional genomics, cellular and tissue biology, neuroscience, drug discovery, and disease mechanisms. Projects should use artificial intelligence to deepen scientific understanding—such as predicting biological function from genetic sequences, revealing cellular dynamics, understanding brain function, modeling molecular interactions, and identifying mechanisms of disease progression or treatment resistance. Overall, the goal is to accelerate scientific discovery and improve precision medicine and therapeutic development through advanced computational and AI approaches. AI should play a central role in the proposed solution and be developed responsibly in line with Google’s Responsible AI Principles, with outputs shared openly (such as open-source tools or datasets) to benefit the broader community. Applicants must present a realistic plan, timeline, and budget, and demonstrate that their team has the expertise needed to carry out the work. Proposals should also show potential for broad impact, explaining how the project’s results could scale, be adopted by others, and remain sustainable across different scientific fields and regions.
04/30/2026	Scott R. MacKenzie Foundation: Grant for Genetic Research	$500,000	Scott R. MacKenzie Foundation	Cancer, Diabetes, Genetics, Genomic Sequencing, Heart Disease, Lung Disease, Oncology	If you are interested in applying to the below opportunity, please contact Amy Cook at [email protected]. LOI due: April 30, 2026 Full application due: June 30, 2026 Amount: Variable up to $500,000 The Scott R. MacKenzie Foundation funds leading-edge human genetic research to advance cures for cancer, lung disease, diabetes and heart disease. Their mission is to provide funding to perpetuate genomic sequencing and genetic research that can impact humanity, improve quality of life, and transform the future health of communities.
04/20/2026	Mark Foundation: Emerging Leader Award	$1,000,000	The Mark Foundation for Cancer Research	Cancer Research, Early Career, Oncology, Young Investigator	If you are interested in applying to the below opportunity, please contact Amy Cook at [email protected]. LOI due: April 20, 2026 Full application due: July 20, 2026 Amount: $1,000,000 (10% indirects) Project period: four years The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. Applicants must be three to eight years from the start of an independent faculty research appointment as of December 31, 2026. Applicants must demonstrate multi-year independent funding (e.g., at least one or two grants such as NIH/R01, NSF/CAREER, or equivalently substantial multi-year awards)
07/01/2026	Focused Ultrasound Foundation: Preclinical Research Program	$150,000	Focused Ultrasound Foundation	Non-invasive Therapy, Preclinical, Translational, Ultrasound	If you are interested in applying to the below opportunity, please contact Amy Cook at [email protected]. LOI due: July 1, 2026 Amount: $150,000 (no indirects) Project period: one year The project must involve the use of non-invasive image-guided focused ultrasound to treat disease. Research priorities include translational studies, mechanisms of action and clinical indications across a wide variety of diseases. PI must be in a tenure track faculty position (academia). Full-time, non-tenure track faculty may be eligible but must have a letter from their institution stating that they are eligible to act as a PI. Postdocs and fellows are eligible for awards but must have a Co-PI that is in a tenure track faculty position.
04/28/2026	PCORI: Broad Pragmatic Studies	$12,000,000	PCORI	Comparative Clinical Effectiveness Research, Diabetes, Obesity, Patient-Centered Outcomes, Sickle Cell Disease, Urogynecological	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Amount: $12,000,000 (plus 40% indirects) Project period: Five years Proposed research will compare existing treatments, services, or healthcare delivery approaches such as medications, screening methods, diagnostic tools, care models, or technologies to determine their relative benefits and harms. The goal is to generate evidence that helps patients, caregivers, clinicians, and healthcare systems make informed decisions that reflect patient needs and preferences. PCORI encourages submissions addressing four Special Areas of Emphasis: interventions for obesity treatment and management; prevention and treatment strategies for diabetes and prediabetes; improved prevention, diagnosis, and management of urogynecological and pelvic pain; and better pain management approaches for individuals living with sickle cell disease. Preferred study designs include randomized controlled trials, though natural experiments and observational studies may also be considered if well designed and adequately powered. All proposals must emphasize clinically meaningful, patient-valued outcomes and include strong engagement from patients and other stakeholders throughout the research process, consistent with PCORI’s partnership expectations. Applicants are also encouraged to evaluate patient-centered burdens and economic outcomes where relevant.
06/12/2026	Aqueduct Foundation and Horne Family Charitable Fund: Rachel Horne Prize	$40,000	Horne Family Charitable Fund	Associate Professor, Female Scientist, Mid-career, Multiple Sclerosis, Women	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: June 12, 2026 Amount: $40,000 Project period: N/A The award recognizes a leading female scientist for their outstanding contribution to women's health-related research in MS. Applicants may self-nominate. Applicants must have an MD or PhD and have worked for more than 15 years at assistant professor level and, at the time of the application, hold the title of associate professor or professor. Applicants must commit to recording a special episode on the ECTRIMS podcast and presenting their work, including global remote meetings or face-to-face meetings organized by iWiMS.
05/27/2026	PhRMA Foundation: Translational Medicine Predoctoral Fellowship	$60,000	PhRMA Foundation	Clinical Collaboration, Diagnostics, Early Career, Precision Medicine, Predoctoral, Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: May 27, 2026 Amount: $60,000 Project period: Two years Supports hypothesis-driven research that moves laboratory discoveries into clinical practice to improve disease prevention, diagnosis, and treatment. Proposals should address unmet clinical needs through innovative diagnostics, therapeutics, precision medicine approaches, biomarker development, AI-enabled modeling, translational PK/PD studies, or human-relevant experimental systems that reduce reliance on animal models. Projects must involve clinical collaboration and include validation in humans or human-derived systems such as biospecimens, clinical datasets, humanized models, or clinical studies. Descriptive projects without a clear therapeutic hypothesis and studies relying solely on animal models are not eligible. Applicants must be full-time PhD students who have completed most pre-thesis requirements (generally at least two years of coursework) and are actively engaged in thesis research when the award begins (April 1–December 1, 2027). Applicants just beginning graduate school or expecting to complete their PhD before December 31, 2027 are ineligible. Candidates must have at least one publication or poster presentation and must devote full time to research during the fellowship; MD/PhD students may not be in required clinical rotations. Individuals with an NIH-F award are ineligible, and fellows may not hold other stipend-supporting awards during the fellowship (institutional trainees may apply if they forgo that support if funded). The award is not intended to support work already funded by a PI’s grants, and only one applicant per lab may apply across the Translational Medicine predoc, postdoc, and faculty starter grant categories.
05/27/2026	PhRMA Foundation: Translational Medicine Postdoctoral Fellowship	$120,000	PhRMA Foundation	Clinical Collaboration, Diagnostics, Early Career, Postdoctoral, Precision Medicine, Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: May 27, 2026 Amount: $120,000 (no indirects) Project period: Two years Supports hypothesis-driven research that moves discoveries from the laboratory to clinical application to improve disease prevention, diagnosis, and treatment. Proposals should address unmet clinical needs through innovative diagnostic, therapeutic, computational, or precision-medicine approaches, including biomarker development, novel clinical endpoints, AI-enabled modeling, translational PK/PD studies, and human-relevant experimental systems that reduce reliance on animal models. Projects must involve clinical collaboration and include validation in humans or human-relevant systems such as clinical biospecimens, real-world datasets, humanized models, or clinical studies. Computational and AI methods must include clear plans for translational validation. Descriptive studies without a clear therapeutic hypothesis and projects relying solely on animal models without human components are not eligible. Applicants must hold a PhD, PharmD, MD, or equivalent research doctorate and be in a postdoctoral position. Applicants are ineligible if their doctoral degree was awarded before January 1, 2024, if they have fewer than two first-author publications, or if they hold an NIH K99/R00 or NIH-F award. Individuals currently supported by institutional training grants (e.g., NIH T32, TL1, T90, or T35) may apply if they agree to forgo that support if funded. Fellows may not hold other stipend-supporting awards during the fellowship, though universities may supplement the stipend. Preference is given to applicants conducting postdoctoral research in a new laboratory, and only one applicant per lab may apply across the Translational Medicine predoc, postdoc, and faculty starter grant categories.
05/27/2026	PhRMA Foundation: Translational Medicine Faculty Starter Grant	$100,000	PhRMA Foundation	Clinical Collaboration, Diagnostics, Early Career, Precision Medicine, Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI deadline: May 27, 2026 Amount: $100,000 (no indirects) Project period: One year Seeks proposals that address unmet clinical needs by developing innovative diagnostic, therapeutic, computational, or precision-medicine approaches that can improve patient care. Projects may include human-relevant model systems, biomarker or endpoint development, AI-enabled modeling, translational pharmacokinetics/pharmacodynamics, and methods that reduce reliance on animal testing. All proposals must be hypothesis-driven, involve clinical collaboration, and include validation in humans or human-relevant systems (e.g., clinical datasets, biospecimens, or humanized models). Projects that are purely descriptive or rely solely on animal models without human validation are not eligible. Applicants are ineligible if their faculty appointment began before January 1, 2025, or if their most recent terminal degree was awarded before January 1, 2017. Applicants are ineligible if they do not have at least three first author publications.
04/15/2026	PhRMA Foundation: Drug Discovery Predoctoral Fellowship	$60,000	PhRMA Foundation	Drug Discovery, Early Career, Predoctoral, Thesis Research, Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: April 15, 2026 Amount: $60,000 (no indirects) Project period: Two years Supports innovative, early-stage drug discovery research with clear potential for translation to human therapeutics. Areas of interest include target identification and validation, multi-omics disease mapping, hit and lead discovery, structural and molecular biology, in vitro and in vivo pharmacology, biomedical imaging, and AI/computational approaches that advance a therapeutic hypothesis. Proposals must present a clear, clinically relevant hypothesis and include rigorous plans for translational validation, particularly for computational and AI-based projects. Applications focused solely on assay development, chemistry without therapeutic evaluation, or biomarker/diagnostic discovery without clinical context will not be considered. Applicants (U.S. and non-U.S. citizens) must be full-time, in-residence PhD students who have completed at least two years of coursework and are engaged in thesis research by award activation (January–August 2027). Applicants must not complete their PhD before December 31, 2027, must have at least one publication or poster presentation, and must devote full time to research (MD/PhD students may not be in clinical training during the award). Individuals holding an NIH-F award, receiving concurrent stipend support, or seeking funding for work already supported by a PI’s active grants are ineligible; students on institutional training grants may apply if they forgo that support if funded.
04/15/2026	PhRMA Foundation: Drug Discovery Postdoctoral Fellowship	$120,000	PhRMA Foundation	Drug Discovery, Early Career, Postdoctoral, Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: April 15, 2026 Amount: $120,000 (no indirects) Project period: Two years Supports innovative, early-stage drug discovery research with strong potential for translation to human therapeutics. Areas of interest include target identification and validation, multi-omics disease mapping, hit and lead discovery, structural and molecular biology, in vitro and in vivo pharmacology, imaging, and AI/computational approaches that advance a therapeutic hypothesis. Proposals must clearly state a clinically relevant hypothesis and include rigorous translational validation plans, particularly for computational and AI-based work. Projects limited to assay development, chemistry without therapeutic evaluation, or biomarker/diagnostic discovery without clinical context are not eligible. Applicants (U.S. and non-U.S. citizens) must hold a PhD, PharmD, MD, or equivalent terminal degree and be postdoctoral at the time of LOI submission. Applicants are ineligible if their doctoral degree was awarded before January 1, 2024, if they have fewer than two first-author publications, or if they hold an NIH K99/R00 or NIH-F award. Those on institutional training grants may apply if they forgo that support if funded. Fellows may not receive concurrent stipend support, and preference is given to candidates training in a new laboratory rather than their graduate lab.
04/15/2026	PhRMA Foundation: Drug Discovery Faculty Starter Grant	$100,000	PhRMA Foundation	Drug Discovery, Early Career, Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due April 15, 2026 Amount: $100,000 (no indirects) Project period is one year Supports innovative, early-stage drug discovery research with clear potential for translation to human therapeutics. Relevant areas include target identification and validation (e.g., CRISPR, phenotypic screening), disease mechanism mapping using multi-omics, hit and lead discovery with molecular modeling, structural biology, cellular and molecular pathway analysis, in vitro and in vivo pharmacology studies, advanced biomedical imaging, and AI/computational approaches that directly advance a therapeutic hypothesis. Proposals must present a clear, therapeutically relevant hypothesis. Computational and AI-based projects must include well-documented methods, transparent data curation, and a feasible plan for translational validation in human-relevant systems. Applications focused solely on assay development, chemistry without therapeutic evaluation, or biomarker/diagnostic discovery without clinical context will not be considered. Funds must be used to conduct the proposed research. Funds may not be used for salary support of the awardee, fringe benefits, or indirect costs. Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty. Ineligible applicants include those who: Began their faculty appointment before January 1, 2025 Received their terminal degree before January 1, 2017 Serve as PI on an NIH R or K award, NSF CAREER award, or other substantial external grant Have fewer than three first-author publications.
04/17/2026	Arthritis Foundation and American Orthopaedic Society for Sports Medicine: Hip Osteoarthritis	$250,000	Arthritis Foundation	Arthritis, Clinical Research, Hip Pathology, Osteoarthritis, Surgery	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due April 17, 2026 Amount: $250,000 (includes 8% indirects) Project period: Two years Supports preliminary research that will establish or advance a programmatic line of research that can eventually result in major external funding, as well as to highlight promising innovative interventions that may be advanced to Phase II clinical trials for patients with or at risk of developing hip osteoarthritis. Studies should identify populations at increased risk—such as individuals with structural hip abnormalities, prior injury or surgery, post-traumatic OA, female athletes, pediatric patients, or those with hip pain but no radiographic OA—and that develop or evaluate new surgical, biologic, pharmacologic, or rehabilitation interventions. Proposals must use clear, evidence-based methods to define and measure OA onset or progression, incorporating clinical symptoms, imaging, biomarkers, risk factors, joint mechanics, surgical history, and the influence of factors such as mental health on functional outcomes. The principal investigator must be an active AOSSM member.
05/16/2026	Triological Society/American College of Surgeons Clinician Scientist Development Awards	$400,000	Triological Society	Early Career, Head and Neck, Otolaryngology, Surgery, Triological	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: May 16, 2026 Amount: $400,000 Project period: Five years The Triological Society and the American College of Surgeons combined competitive grant program provides supplemental funding to otolaryngologists-head and neck surgeons who have received a new NIH Mentored Clinical Scientist Development Award (K08/K23) or have an existing award with a minimum of 3 years remaining in the funding period as of October 1 of the application year. Applicants must be Associate Fellows or Fellows of the American College of Surgeons.
04/03/2026	Google.org Impact Challenge: AI for Government Innovation	$1,000,000	Google	Artificial Intelligence (AI), Health, Preventative Medicine	If you are interested in applying to the below opportunity, please contact Amy Cook at [email protected]. Full submission due: April 3, 2026 Amount: $1-$3M Proposals should address a critical public service challenge through data-driven solutions that drive significant, measurable outcomes for communities, leverage strong government partnerships, and demonstrate a deep understanding of how end beneficiaries will be reached and supported. With a focus on health, the goal is to enhance public systems so more effective healthcare services can reach all citizens, regardless of location. For example, by leveraging generative and agentic AI to create seamless “front door” access to services, improve frontline health worker capacity, or drive population-scale preventive care that ensures no community is left behind.
04/15/2026	PhRMA Foundation: Drug Delivery Predoctoral Fellowship	$60,000	PhRMA Foundation	Drug Delivery, Early Career, Predoctoral, Thesis Research, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 15, 2026 Amount: $60,000 (no indirects) Project period: two years Funds therapeutically focused research to improve the formulation, manufacturing, delivery, and in vivo performance of complex drugs to enhance safety, effectiveness, and clinical viability. Priorities include optimizing composition and dosage to achieve desired PK/PD, advancing CMC processes for challenging molecules, and developing predictive or AI approaches that link product quality to efficacy and toxicity. Proposals must define a specific therapeutic payload and target tissue, justify dosing feasibility, and include biodistribution and translational validation plans (with clear methodology for computational work); platform-only projects without a defined payload or disease context are not eligible. Applicants (U.S. or non-U.S. citizens) must be full-time, in-residence PhD who have completed at least two years of coursework, are engaged in thesis research by award activation (January 1–August 1, 2027), and will not complete their PhD before December 31, 2027. Applicants must have at least one publication or poster, devote full time to research (MD/PhD students may not be in clinical training during the award), and may not hold NIH-F awards or concurrent stipend support (though institutional supplementation is allowed); those on institutional training grants must relinquish that support if funded, and the fellowship cannot support work already funded by a PI’s active grants.
04/15/2026	PhRMA Foundation: Drug Delivery Postdoctoral Fellowship	$120,000	PhRMA Foundation	Drug Delivery, Early Career, Post Doc, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 15, 2026 Amount: $120,000 (no indirects) Project period: Two years The PhRMA Foundation supports therapeutically focused research to improve the formulation, manufacturing, delivery, and in vivo performance of complex drugs, with the goal of enhancing safety, effectiveness, and clinical feasibility. Areas of interest include optimizing composition, dosage, and delivery to achieve desired PK/PD; advancing CMC processes for challenging molecules; and developing predictive modeling or AI approaches that link product quality to efficacy and toxicity. Proposals must define a specific therapeutic payload and target tissue, justify dosing feasibility, and include plans for biodistribution and translational validation (with clear methodology and data documentation for computational work); platform-only proposals without a defined payload or disease context are not eligible. Applicants (U.S. or non-U.S. citizens) must be postdoctoral researchers at an accredited U.S. PhD- or MS-granting university, hold a PhD, PharmD, MD, or equivalent terminal degree earned on or after January 1, 2024, and have at least two first-author publications. They are ineligible if they hold NIH K99/R00 or F awards and may not receive concurrent stipend support (though institutional supplementation is allowed); those on institutional training grants may apply but must relinquish that slot if funded. Preference is given to candidates training in a new laboratory rather than their graduate lab.
04/15/2026	PhRMA Foundation: Drug Delivery Faculty Starter Grant	$100,000	PhRMA Foundation	Drug Delivery, Early Career, Formulation Optimization, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due April 15, 2026 Amount: $100,000 (no indirects) Project period: One year Supports therapeutically relevant research that advances drug formulation, manufacturing, and delivery to improve safety, effectiveness, and clinical viability. Areas of interest include optimizing drug composition and dosage for desired PK/PD, CMC process development for complex molecules, and predictive modeling or AI approaches to link product quality with in vivo performance and toxicity. Proposals must define a specific therapeutic payload and target tissue, justify dosing and PK/PD feasibility, and include plans for biodistribution and translational validation, particularly for computational work. Platform technologies without a clear payload, disease context, or path to feasibility are not eligible. Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty. Applicants are ineligible if their faculty appointment began before January 1, 2025, their terminal degree was conferred before January 1, 2017, they serve as PI on an NIH R/K, NSF CAREER, or other substantial award (generally >$250,000/year), or they have fewer than three first-author publications. Preference is given to applicants with limited startup funding (under $750,000).
03/30/2026	PCORI: Engagement Award: Convening Support	$125,000	PCORI	Convening, Dissemination of Findings, Engagement	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due March 30, 2026 Amount: $125,000 (includes 40% indirects) Project period: One year Supports multi-stakeholder convenings—not research studies—that advance patient-centered comparative clinical effectiveness research (CER). Projects must meaningfully engage patients, caregivers, and other healthcare stakeholders and fall into one of two tracks: (1) convening to prioritize or advance patient-centered CER, or (2) convening to disseminate findings from previously PCORI-funded research. Eligible activities include conferences or in-person/virtual meetings that foster collaboration and produce actionable deliverables (e.g., research priorities, dissemination strategies), but not webinars, focus groups, or new research. Convening must produce at least one deliverable that facilitates collaborators to take part in and/or disseminate patient-centered CER in the future.
04/13/2026	Karen Toffler Charitable Trust: Toffler Scholar Grant	$40,000	Karen Toffler Charitable Trust	Early Career, Neurodegenerative disease, Neurological Disease, Neuroscience, PhD Candidates, Post Doc	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due April 13, 2026 Amount: $40,000 Project period: One year The Toffler Scholar Grant supports early-career researchers pursuing bold, interdisciplinary work that advances our understanding of the brain and improves human health. The program invests in scientists (PHD candidates, Post Doc, Assistant Professors) whose innovative ideas have the potential to drive transformative breakthroughs but may fall outside traditional funding pathways. Application requires a short video (no more than five minutes) in which you speak in your own words about why you are seeking support from the Karen Toffler Charitable Trust.
04/14/2026	International OCD Foundation: Innovator Award	$300,000	International OCD Foundation	Established Investigator, OCD	If you are interested in the following opportunity, please contact Karineh Petrossian at [email protected]. Application due: April 14, 2026 Amount: $300,000 (no indirects) Project period: Three years Supports innovative and potentially groundbreaking projects by seasoned researchers— high-impact science that could profoundly impact the field and accelerate progress toward new and more effective treatments for OCD.
04/14/2026	International OCD Foundation: MJ Young Investigator Awards	$50,000	International OCD Foundation	Early Career, OCD	If you are interested in the following opportunity, please contact Karineh Petrossian at [email protected]. Application due: April 14, 2026 Amount: $50,000 (no indirects) Project period: One year Supports projects investigating OCD, body dysmorphic disorder (BDD), hoarding disorder, or other disorders related to OCD.
03/30/2026	Alzheimer's Drug Discovery Foundation: The Treat FTD Fund	$2,500,000	Alzheimer's Drug Discovery Foundation	Biomarkers, Drug Development, Early-Stage Clinical Trials, Frontotemporal Dementia, Mechanism Driven Therapeutics, Rare	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: March 30, 2026 Amount: $2,500,000 Project timeline: Three years The Treat FTD Fund supports early clinical development of drugs or devices for frontotemporal dementia (FTD), with an emphasis on advancing mechanistic understanding and validating biomarkers with a clearly defined context of use. The goal is to de-risk development programs by funding clinical trial readiness activities and Phase 0–2 trials that include clear go/no-go criteria for later-stage advancement. Eligible projects may evaluate novel or repurposed therapeutics, including both disease-modifying and symptomatic approaches. Competitive proposals should demonstrate: A strong biological rationale relevant to FTD pathophysiology Biomarkers assessing target engagement and pharmacologic/biological effect Trial designs appropriate for rare disease populations Outcome measures that inform mechanism and disease progression Applicability to sporadic and/or genetic FTD (sporadic FTD trials particularly encouraged) While proposals addressing all elements are preferred, well-justified early-stage trials grounded in sound biology will be considered.
05/11/2026	Alzheimer's Drug Discovery Foundation: Accelerating Drug Discovery for Frontotemporal Degeneration	$300,000	Alzheimer's Drug Discovery Foundation	Drug Repurposing, Frontotemporal Dementia, In Vivo, Novel Therapeutics	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: May 11, 2026 Amount: $300,000 Project timeline: One year (option to extend with additional funding) All funding provided by the ADDF is through mission-related investments that require return on investment based upon milestones. Return on investment can include equity, convertible notes or royalties and are determined on a case-by-case basis. The RFP supports: Lead optimization of novel disease-modifying compounds, including medicinal chemistry refinement and in vitro ADME. In vivo testing of novel lead compounds, biologics, vaccines or repurposed drug candidates in relevant animal models for pharmacokinetics, dose-range finding, target engagement, in vivo efficacy, and/or preliminary rodent tolerability studies. This RFP does not support target identification, target validation, assay development, high-throughput and high-content screening. The strongest applications will test a compound that has met many or all of the following criteria: Chemical structures of hits and leads have been assessed for structural liabilities Novel composition of matter patents have been filed or plans to generate novel composition of matter intellectual property have been developed The strongest applications will test a repurposed or repositioned drug that has met many or all of the following criteria: The known side effects of the drug and how well they would be tolerated by the intended FTD population have been evaluated A supplier has been identified that will provide sufficient quantities of the drug or compound to complete the study aims Plans to develop novel IP around the repurposing/repositioning strategy have been considered Applications that include preclinical efficacy studies should: Provide data demonstrating blood-brain barrier penetration (if the intended target is in the CNS) Justify dose, route of administration, and regimen with in vivo PK/PD data. If this data is not yet available, a PK/PD study aim should be included in the proposal Include measures of target engagement in the proposed animal study design Include measures to assess off-target effects with the potential to interfere with behavioral outcome measures (e.g., sedation)
05/01/2026	Pew Charitable Trusts: Pew Biomedical Scholars – Limited Submission	$300,000	Pew	Biomedical Research, Early Career, Limited Submission	If you are interested in the following opportunity, please contact Carole King at [email protected]. Internal application deadline: May 1, 2026 Amount: $300,000 (includes 8% indirects) Project period: Four years This is a university-wide limited submission opportunity coordinated by the USC Provost’s Office. The process begins with an internal competition requiring a two-page research proposal and the PI’s CV. A faculty review committee will evaluate submissions and select the nominees who will be invited to advance to the external application stage with the sponsor. The internal deadline is pending. Candidates must hold a doctorate in biomedical sciences or a related field and run an independent lab with a full-time appointment as an assistant professor (research, adjunct, visiting, or instructor titles are not eligible). Applicants must not have established an independent lab before June 10, 2023 (excluding clinical training or parental leave), may apply no more than twice, must be institutionally nominated, and may not apply simultaneously to the Pew Scholars and Pew-Stewart Cancer Research programs. Proposals should reflect exceptional promise and highly creative, high-impact biomedical research (clinical trials are not supported), and selection is based on both the project’s strength and the investigator’s demonstrated independence and accomplishments. It is expected that Pew scholars will spend at least 80 percent of their time on research.
03/31/2026	Scleroderma Research Foundation: New Faculty Grants	$75,000	Scleroderma Research Foundation	Early Career, Scleroderma	If you are interested in the following opportunities, please contact Karineh Petrossian at [email protected]. Application due: March 31, 2026 Amount: $75,000 (no indirects) Project period: Two years The funding supports the development of research that will advance the understanding of the pathogenesis of scleroderma and to promote the design, development, and pilot testing of hypothesis-driven, innovative therapeutic approaches.
03/31/2026	Scleroderma Research Foundation: Exploratory/Developmental Grant	$75,000	Scleroderma Research Foundation	Preclinical, Scleroderma	If you are interested in the following opportunities, please contact Karineh Petrossian at [email protected]. Application due: March 31, 2026 Amount: $75,000 (no indirects) Project period: Two years The funding supports cross-disciplinary approach toward scleroderma research and adaption of proven technologies from other disciplines to advance the understanding of disease pathogenesis. Investigators may also conduct small-scale clinical projects, including observational or retrospective studies. They may gather pre-clinical data or obtain preliminary data on toxicity and efficacy in a limited number of patients.
03/31/2026	Scleroderma Research Foundation: Investigator-Initiated Research Grant	$200,000	Scleroderma Research Foundation	Scleroderma	If you are interested in the following opportunities, please contact Karineh Petrossian at [email protected]. Application due: March 31, 2026 Amount: $200,000 (no indirects) Project period: Three years will be considered The funding supports the development of research that will advance the understanding of the pathogenesis of scleroderma and to promote the design, development, and pilot testing of hypothesis-driven, innovative therapeutic approaches. The Foundation also seeks to advance research by promoting collaboration and cross-institutional cooperation among scientists in a variety of disciplines, attracting promising new scientists to scleroderma research, and bringing new technology and thinking to the field of scleroderma research.
04/15/2026	American Federation for Aging Research: McKnight Innovator Award	$750,000	American Federation for Aging Research	Basic Biologic Mechanism, Clinical Translational Research, Cognitive Aging, Early Career, Memory	If you are interested in the following opportunity, please contact Amy Cook at [email protected] or Carole King at [email protected]. · LOI Due: April 15, 2026 · Amount: $750,000 (10% indirects) · Project Period: Three years Supports independent investigators at the Assistant or Associate Professor level with established research programs and a demonstrated commitment to cognitive aging. Two awards will be made: one for clinical translational research and one for basic biological mechanisms underlying cognitive aging and memory loss. Projects should be high risk and high gain, potentially including pilot clinical trials, proof-of-concept interventions, preclinical studies, or mechanistic research aimed at identifying novel treatment targets. Basic science proposals must clearly articulate translational potential. Studies intersecting aging and disease-related cognitive impairment may be considered if clearly focused on cognitive aging, but projects primarily centered on neurodegenerative diseases such as Alzheimer’s disease are not eligible.
05/01/2026	Huo Family Foundation: Effects of the Usage of Digital Technology on Brain Development, Social Behaviors and Mental Health in Children and Young People - Junior Faculty	$688,500	The Huo Family Foundation	Brain Development, Digital Technology, Early Career, Junior Faculty, Mental Health, Youth	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due May 1, 2026 Amount: $688,500 (includes 12.5% indirects) Project period: Three years The Huo Family Foundation invites junior faculty research grant applications to support early-career lecturers or assistant professors in developing independent research programs and leading projects or teams. Proposals must address the impact of digital technology use and exposure on brain development, social behavior, and the mental health and well-being of children and young people. Grant funds are not to be used to support the lead applicant’s salary. This opportunity excludes funding for new epidemiological cohorts, clinical service reorganization, animal studies, and systematic reviews. It also does not support projects involving digital technologies for mental health treatment or education, or randomized trials testing drugs, medical devices, diagnostics, or mental health intervention apps.
05/01/2026	Huo Family Foundation: Effects of the Usage of Digital Technology on Brain Development, Social Behaviors and Mental Health in Children and Young People – Early Career Fellowship	$526,000	The Huo Family Foundation	Brain Development, Digital Technology, Early Career, Mental Health, Post Doc, Youth	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application Due: May 1, 2026 Amount: $526,000 (includes 12.5% indirects) Project Period: Three years Proposals should address the broad topic of the effects of usage of and exposure to digital technologies on brain development and function (including physiological responses), social behavior and interactions, and the well-being and mental health of children and young people. Applicants must be postdoctoral researchers on the path to independence. Typically, the researchers must be within four years of completing PhD and without their first permanent position. This funding opportunity does not support new epidemiological cohorts, clinical service reorganization, animal studies, systematic reviews, or randomized trials involving drugs, medical devices, diagnostic procedures, or mental health intervention apps. It also excludes projects focused on developing or deploying digital technologies to deliver mental health treatment or educational learning.
03/23/2026	MTF Biologics: Innovation in Allografts Translational Grants	$225,000	MTF Biologics	Acellular Dermal Matrix, Allograft, Early Career, Orthopedics, Plastic Surgery, Regenerative Medicine, Skin Tissue Engineering, Translational Research	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. LOI due: March 23, 2026 Amount: $225,000 Project period: Three years Supports high-impact translational and clinical research that advances allograft tissue science and improves patient outcomes. Projects must use allograft tissues or derivatives and demonstrate a clear path to clinical translation; autologous, synthetic-only, or non-allograft approaches are not eligible. Areas of interest include orthopaedics, plastic and reconstructive surgery, soft-tissue and abdominal wall repair, wound care, and other specialties where allografts improve care. Priority topics include novel allograft applications; combination strategies with biomaterials or biologics; technologies that enhance processing, preservation, or biologic function; tissue engineering and regenerative medicine platforms; real-world evidence and health economics; extracellular vesicles and secretome research; and AI- or genomics-based approaches to optimize donor selection and graft performance. Qualified applicants may apply under one of the following tracks: Junior Investigator: One‑year, $75,000 award for investigators without prior major independent funding. Established Investigator: Three‑year, $225,000 award for investigators with prior major grant support.
03/23/2026	MTF Biologics: Dermal Allograft Innovation Grants	$100,000	MTF Biologics	3D Bioprinting, Dermal Allograft, Orthopedics, Plastic Sugery, Regenerative Medicine, Skin Tissue Engineering, Wound Care	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. LOI due: March 23, 2026 Amount: $100,000 Project period: one year Priority areas include flowable or particulate ADM, tissue-engineered or viable dermal constructs, 3D bioprinting integration, advanced processing and room-temperature preservation, and novel product designs that enhance clinical performance. Eligible projects must center on meaningful technological innovation in allograft-based products; incremental updates to traditional sheet formats or non-allograft technologies are excluded.
04/08/2026	Wellcome Trust: Climate Impacts Awards	$2,500,000	Wellcome Trust	Climate, Environment, Mental Health, Mid-career Researcher, Physical Health, Policy	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due: April 8, 2026 Amount: $2,500,000 (including 20% indirects) Project period: three years The aim of this program is to make the physical and mental health impacts of climate change visible in order to catalyze urgent, large-scale climate policy action. Supports transdisciplinary teams to deliver short-term, high-impact projects that combine rigorous evidence generation or synthesis with strategic policy engagement. In addition to closing critical evidence gaps, the program will support research that clarifies the economic consequences of climate-related health outcomes to strengthen the case for action.
05/29/2026	March of Dimes: Basil O’Connor Starter Scholar Research Awards	$150,000	March of Dimes	Early Career, Mid-career, Newborns, Postpartum, Pregnancy, Preterm Birth, Translational Research	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due: May 29, 2026 Amount: $150,000 Project period: Two years Supports research on serious medical conditions that affect maternal health during pregnancy and the health of mothers and newborns through the first year postpartum. Open to investigators who, at the time of award, are 4–9 years beyond completion of required clinical training for medical specialty board certification (MD or MD/PhD) or beyond receipt of their terminal degree (PhD). MD/PhD applicants must hold a full-time, tenure-track (or equivalent) faculty position at a U.S.-based institution. PhD applicants must have a primary or secondary appointment in a clinical department related to maternal or child health.
03/31/2026	Society for Surgery of the Alimentary Tract: Career Development Award	$150,000	The Society for Surgery of the Alimentary Tract	Alimentary Tract, Early Career, Gastrointestinal (GI) Tract, Surgery	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due: March 31, 2026 Amount: $150,000 Project period: Two years The supported research program can be focused on basic laboratory or rigorous clinical investigation. The award is restricted to surgeons who have completed formal clinical and research training in general surgery and are within five years of their first faculty appointment in a department of surgery at a medical school.
03/16/2026	The Triological Society: TRIO Research Career Development Award	$40,000	Triological Society		If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due: March 16, 2026 Amount: $40,000 Project period: Two years Support for the research career development of otolaryngologists-head and neck surgeons. Projects must have a direct impact on the applicant’s ability to pursue his/her long-range research objectives.
07/31/2026	Elevance Health Foundation: Maternal / Infant Health	$1,000,000	Elevance Health Foundation	Infant Health, Maternal Health, Maternal Morbidity	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: July 31, 2026 Amount: Approximately $1,000,000 (15% indirects). Amount is not specified by the funder. Project period: Up to three years Grant funding for programs that improve maternal/ infant health, target disparities, address social needs, and remove barriers to care throughout the pregnancy journey—from pre-conception support to postnatal care for mothers and babies. Proposed programs should support one or more of the following goals: Reducing disparities in pre-term birth rates Reducing disparities in severe maternal morbidity (SMM) incidence Improving maternal/infant health outcomes Priority consideration will be given to programs that advance whole-person health through culturally responsive, trust-building interventions that address health-related social needs, demonstrate measurable outcomes, and offer innovative, scalable solutions.
04/28/2026	PCORI: Addressing Sensory Health Needs Across the Lifespan	$12,000,000	PCORI	Balance, Hearing, Mental Health, Senses, Sensory health conditions, Vision	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Budget: $12 million (plus 40% indirects) Project period: five years Sensory health conditions affect one or more sensory systems including vision, hearing, smell, touch, taste and balance and can arise across the lifespan. These conditions impact communication, mobility, access to information and quality of life, with significant disparities in access to care and outcomes. Sensory conditions are linked to increased mortality, cognitive decline and poor mental health, underscoring the need for timely screening, coordinated care and support services. This PCORI funding announcement seeks patient-centered comparative effectiveness research (CER) to address evidence gaps in screening, treatment, care coordination and support services for individuals with sensory health conditions and their care partners. PCORI encourages applications addressing: (1) improved screening and early detection, particularly in underserved communities; (2) treatments and care models that enhance access and coordination across health systems; and (3) support services that address mental health and stigma using patient- and family-centered, interdisciplinary approaches. Applicants are strongly encouraged to propose individual- or cluster-randomized controlled trials; however, well-specified natural experiments and well-designed observational studies will also be considered.
04/01/2026	Laerdal Foundation: Resuscitation, Trauma, Maternal &/or Newborn Care	$50,000	Laerdal Foundation	Birth, Cardiac Arrest, Child Health, Research, Trauma	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. Application due: April 1, 2026 Amount: $30,000 - 50,000 (10% indirect costs) Project period: one year The Foundation in particular welcomes applications that can advance treatment recommendations, education, or implementation within: Resuscitation. Trauma. Maternal and/or newborn care.
03/30/2026	J. Macy Jr. Foundation: Ensuring Fairness in Clinical Assessment	$200,000	Josiah Macy Jr. Foundation	Clinical, Medical Education	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. LOI due: March 30, 2026, 8:59pm PT Proposal due (per invite): July 17, 2026 Amount: $200,000 (10% indirect costs) Project timeline: two years Projects should serve as models for how medical schools can implement assessment strategies that remain focused on their core purpose: ensuring that every graduate is fully prepared to deliver the highest standard of patient care.
04/22/2026	The American Speech-Language-Hearing Foundation (ASHFoundation): New Century Scholars Research Grant	$25,000	American Speech Language Hearing Foundation	Audiology, Hearing, Speech-language pathology	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due: April 22, 2026 Amount: $25,000 (no indirects) Project period: two years While proposal type and content area are not restricted, this grant supports studies that are innovative, have a promise of major impact, or can meet research needs not yet addressed. For researchers (with a PhD or equivalent research doctorate in CSD).
04/22/2026	American Speech-Language-Hearing Foundation (ASHFoundation): Researcher-Practitioner Collaboration Grant	$35,000	American Speech Language Hearing Foundation	Audiology, Hearing, Speech-language pathology	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due: April 22, 2026 Amount: $35,000 (no indirects) Project period: two years The Researcher-Practitioner Collaboration Grant supports partnerships between academic or organizational researchers and clinical practitioners to conduct collaborative studies designed to enhance evidence for improving communication sciences and disorders (CSD) services. This grant is designed to support preliminary research that will lead to a larger-scale study. The collaborative effort is central to this unique funding opportunity. University clinics may serve as practice settings. Clinicians or clinical supervisors with the university clinic setting may serve in the practitioner role.
05/04/2026	Winn Career Development Award for Early-stage Investigator Physicians	$120,000	Bristol Myers Squibb	Career Development	Program Goal: This rigorous two-year program supports the career development of early-career investigator-physicians through structured education and mentorship on community-oriented clinical trial design and implementation. Through this work we ensure treatments developed are safe and effective for all who will use them and that more communities have access to the latest advances in medicine. Eligibility: Must have a demonstrated commitment to improving patient participation in clinical trials. Must be a physician (MD, DO, or international equivalent) AND have an active US medical license. Must be a US Citizen or Lawful Permanent Resident. Must focus on one of the following clinical research areas: cancer, cardiovascular and cardiometabolic diseases, and neuropsychiatry. Must currently be in the first to eighth year of a full-time clinical faculty appointment. Contact: Direct questions to [email protected]
03/18/2026	Sontag Foundation Distinguished Scientist Award	$750,000	The Sontag Foundation	Brain Cancer, Early Career	If you have a faculty member interested in applying to the opportunity below, please contact Amy Cook at [email protected]. Application Due: March 18, 2026 Amount: $750,000 over five years. Indirect costs set at 13%. The Distinguished Scientist Award (DSA) seeks to provide career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research. Applicants must have received their first independent faculty appointment no earlier than March 1, 2021 and no later than January 1, 2026.
03/16/2026	The Glaucoma Foundation	$75,000	The Glaucoma Foundation	Artificial intelligence, Genomic Medicine, Glaucoma	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: March 16, 2026 Amount: $75,000 (renewable for an additional year at $75,000) (no indirects) Project timeline: one year The areas of focus are Exfoliation Syndrome and Exfoliation Glaucoma, Pressure Independent Mechanisms of Glaucoma, Neuroprotection, and Genetics of Glaucomas that affect people under the age of 40 years. Examples of research that may be considered range from basic science to clinical interventions, such as genetics and genomic medicine, disease modeling, assessment of ocular perfusion, artificial intelligence, and clinical research. The Glaucoma Foundation does not provide funds for investigator salaries, travel, overhead or other indirect costs. However, technician salaries are eligible.
03/15/2026	American Orthopaedic Society for Sports Medicine: JRF Ortho Allograft Grant	$50,000	American Orthopedic Society for Sports Medicine	Allograft Transplant, Basic Science, Clinical Research, Knee	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due: March 15, 2026 Amount: $50,000 (no indirects) Project period: one year With JRF Ortho, AOSSM is offering support for a basic science or clinical research project to advance insight into meniscal or osteochondral allografts. Applications must describe a basic science or a clinical research project surrounding viable Osteochondral Allograft (OCA) transplantation or meniscus allograft transplantation of the knee. Criteria and metrics utilized in the study must be determined by best scientific evidence or best demonstrated practices and designed to improve the understanding of, and research evidence regarding, OCA or meniscus allograft transplantation. Proposals with translational or advancement of clinical care will be reviewed favorably.
03/17/2026	International Human Frontier Science Program: Research Grants	$1,500,000	Human Frontier Science Program	Basic Science, Interdisciplinary, International Team, Life Science	If you are interested in the following opportunity, please contact Carole King at [email protected]. Initiate LOI process: March 17, 2026 LOI submission due: March 26, 2026 Amount: $1,500,000. Awards are fixed sums dependent upon team size. No indirects. Project timeline: three years. Funds high-risk, fundamental science questions about how living systems work, particularly those that open new scientific directions and involve interdisciplinary teams. The research team must be international (preferably intercontinental). Explicitly excludes “applied research, including medical research typically funded by national medical research bodies.” Budgets are not required. Awarded teams receive a fixed sum, over three years, depending on team size (four member teams receive $500,000 annually, if all members have their labs in different countries). No salary support (including summer salaries) can be paid from the grant for the Principal Applicant, Co-Applicant or other faculty, institutional staff such as secretaries or laboratory managers, and no student tuition fees can be paid.
03/16/2026	Wellcome Trust: Genomics in Context Research Awards	$500,000	Wellcome Trust	Bioethics, Genomics, Humanities, Interdisciplinary Research	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due: March 16, 2026 Amount: $500,000 (including 20% indirects) Project period: two years These awards aim to fund transdisciplinary teams that integrate genomics, humanities, social sciences, and bioethics to create innovative research agendas. Current approaches often include ethical and social perspectives too late, limiting both ethical practice and discovery potential. The call encourages: Broader collaboration across diverse disciplines and societal partners. Early engagement of partners during research ideation and design. Emphasis on discovery-driven research rather than retroactive ethical evaluation. Integrated collaboration throughout the research lifecycle to leverage diverse skills and perspectives.
09/14/2026	Alzheimer's Drug Discovery Foundation: Prevention	$5,000,000	Alzheimer's Drug Discovery Foundation	Alzheimer's, Alzheimer's Prevention, Human Studies	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: September 14, 2026 Budget: $5,000,000 (no indirects) Project period: Multi-year Funds human studies on precision prevention, combination therapies, and comparative effectiveness to reduce Alzheimer’s and related dementia risk. Eligible studies target primary or secondary prevention populations, focus on modifiable risk factors, and measure outcomes such as cognition or biomarkers. Lifestyle-only interventions are excluded, but combinations with drugs, supplements, or devices are eligible. Priority goes to novel or repurposed therapeutics with strong commercial or IP potential.
09/14/2026	Alzheimer's Drug Discovery Foundation: Neuroimaging and CSF Biomarker	$600,000	Alzheimer's Drug Discovery Foundation	Alzheimer's, Biomarkers	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: September 14, 2026 Budget: $600,000 (no indirects) Project period: one year This RFP aims to further develop and validate established biomarkers with clear clinical value in Alzheimer’s disease and related dementias. It prioritizes biomarkers with a defined context of use, clear advantages over existing options, and a pathway to commercialization or clinical application, focusing on novel PET ligands, CSF biomarkers, innovative MRI approaches, and new measures of functional activity such as EEG.
09/14/2026	Alzheimer's Drug Discovery Foundation: Drug Development	$5,000,000	Alzheimer's Drug Discovery Foundation	Alzheimer's, Drug Discovery	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: September 14, 2026 Amount: $5,000,000 (no indirects) Project Period: Multi-year Funds IND-enabling studies and early-phase clinical trials of promising drugs or devices for Alzheimer’s and related dementias, focusing on diverse, novel mechanisms tied to the biology of aging and emerging therapeutic areas. Anti-amyloid and cholinesterase inhibitor approaches are excluded. Up to $5,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment.